Lymphadenectomy with tumors of the upper gastrointestinal tract;Lymphadenektomie bei tumoren des oberen gastrointestinaltraktes

Chirurg

Volumn 78, Issue 3, 2007, Pages 203-216

  Schuhmacher, C ^a   Novotny, A ^a   Ott, K ^a   Feith, M ^a   Siewert, J R ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

AEG; Barrett; Gastric cancer; Lymphadenectomy; Oesophageal cancer

Indexed keywords

ADENOCARCINOMA; BARRETT ESOPHAGUS; CANCER STAGING; CARDIA; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METHODOLOGY; MORTALITY; PATHOLOGY; PRECANCER; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA; STOMACH TUMOR; THORACIC CAVITY;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CARCINOMA, SQUAMOUS CELL; CARDIA; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROGNOSIS; STOMACH NEOPLASMS; THORACIC CAVITY;

EID: 33947541728     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-007-1307-7     Document Type: Review

References (29)

1. Akiyima H, Tsurumaru M, Kawamura T et al. (1992) Background of lymph node dissection for squamous cell carcinoma of the esophagus. In: Sato T, Iizuka T (Hrsg) Color Atlas of Surgical Anatomy for esophageal cancer. Springer Heidelberg, pp 9-24
2. Barbour AP, Rizk NP, Gonen M et al. (2006) Lymphadenectomy for adenocarcinoma of the gastroesophageal jXunction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol Epub PMID: 1309-1329
3. Bartels H, Stein HJ, Siewert JR (1998) Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 85: 840-844
4. Cunningham D, Allum WH, Stenning SP et al. (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355: 11-20
5. Cuschieri A, Fayers P, Fielding J et al. (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 13(347): 995- 999
6. Degiuli M, Sasako M, Galgaro M et al. (2004) Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric cancer Study Group (IGCSG) randomised surgical trial Eur J Surg Oncol 30: 303-308
7. Doki Y, Ishakawa O, Takachi K et al. (2005) Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma. World J Surg 29: 700- 707
8. Feith M, Stein HJ, Siewert JR (2006) Adenocarcinoma of the esophagogastric junction: Surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin N Am 15: 751-764
9. Geh JI, Crellin AM, Glynne-Jones R (2001) Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 88: 338-356
10. Hartkrink HH, Velde CJH van de, Putter H et al. (2004) Extended Lymph Node dissection for gastric cancer: who may benefit? Final results of the randomized dutch gastric cancer group trial. J Clin Oncol 22: 2069-2077
11. Igaki H, Tachimori Y, Kato H (2004) Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field lymphadenectomy. Ann Surg 239: 483-490
12. Kampschoer GH, Maruyama K Velde CJ van der et al. (1989) Computer analysis in making preoperative decisions: a rational approach to lymph node dissection in gastric cancer patients. Br J Surg 76: 905-908
13. Kitagawa Y, Fuji H, Mukai M et al. (2002) Radioguided sentinel node detection for gastric cancer. 89: 604-608
14. Kitagawa Y, Kitajima M (2006) Diagnostic validity of radio guided sentinel node mapping for gastric cancer: a review of current status and future direction. Surg Technol Int 15: 32-36
15. Lerut T, Flamen P, Ectors N et al. (2000) Histopathologic validation of lymph node staging with FDGPET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 232: 743-752
16. MacDonald JS, Smalley SR, Benedetti J et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725-730
17. Motoyama S, Kitamura M, Saito R et al. (2006) Outcome and treatment strategy for mid- and lowerthoracic esophageal cancer recurring locally in the lymph nodes of the neck. World J Surg 30: 191- 198
18. Peeters KC, Hundahl SA, Kranenbarg EK et al. (2005) Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1-D2 trial. World J Surg 29: 1576-1584
19. Sano T, Sasako M, Yamamoto S et al. (2004) Gastric Cancer surgery: morbidity and mortality results from a prospective randomised controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan Clinical Oncology Group study 9501. J Clin Oncol 15(22): 2767-2773
20. Shimada H, Okazumi S, Matsubara H et al. (2006) Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three field lymph node dissection. World J Surg 30: 1441- 1449
21. Siewert JR, Bartels H, Stein HJ (2005) Abdominorechts- thorakale Ösophagusresektion mit intrathorakaler Anastomose beim Barrett-Karzinom. Chirurg76(6): 588-594
22. Siewert JR, Böttcher K, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer: tenyear results of the german gastric cancer study. Ann Surg 228: 449-461
23. Siewert JR, Kestlmeier R, Busch R et al. (1996) Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastasis. Br J Surg 83: 1032-1033
24. Siewert JR, Lordick F (2006) Response-Vorhersage - frühe Response Evaluation. Chirurg 77: 1095- 1103
25. Stein HJ, Feith M, Mueller J, Werner M, Siewert JR (2000) Limited resection for early adenocarcinoma in Barrett's esophagus. Ann Surg 232: 733-742
26. Tabira Y, Okuma T, Sakaguchi T et al. (2004) Three field dissection or two-field dissection? A proposal of new algorithm for lymphadenectomy. Hepatogastroneterology 51: 1015-1020
27. Weber WA, Ott K, Becker K (2006) Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic. Imaging J Clin Oncol 19: 3058-3065
28. Siewert JR, Rothmund M, Schumpelick V (2006) Praxis der Viszeralchirurgie: Onkologische Chirurgie. Springer, Heidelberg, S 408-467
29. Sato T, Iizuka (1992) Color Atlas of Surgical Anatomy for Esophageal Cancer. Springer, Tokyo, S 15- 28